CD25-Targeted Regulatory T Cell Depletion: Efficacy of Anti-CD25 Antibody Fragments in Near-Infrared Photoimmunotherapy
Medical Supporter — إشعار معلوماتي
هذه المقالة ملخص لمعلومات طبية دولية وليست نصيحة طبية، ولا يمكن أن تحل محل تشخيص طبيبك المعالج أو خطة العلاج. المعلومات المعروضة مجمّعة من منشورات عامة وبيانات رسمية لكبرى المؤسسات الطبية اليابانية؛ وتختلف ملاءمة ونتائج أي علاج من مريض لآخر ويجب أن يقيّمها طبيب مؤهل لكل حالة على حدة.
- November 21, 2019
- 1 min read
Regulatory T (Treg) cells represent an immunosuppressive mechanism that enables cancer cells to evade immune surveillance. Depletion of intratumoral Treg cells may lead to tumor regression. However, complete elimination of Treg cells could also damage the immune system. Near-infrared photoimmunotherapy (NIR-PIT) is a treatment modality that causes selective cell death of specific cells within the tumor.
An antibody-photoabsorber (IRDye700DX) conjugate (APC) binds to the tumor and, upon irradiation with near-infrared (NIR) light, causes rapid death of these cancer cells. CD25-targeted NIR-PIT has been shown to induce depletion of Treg cells within the tumor microenvironment.
In this preclinical study, researchers compared the efficacy of the antibody fragment anti-CD25-F(ab')2-IR700 versus the intact antibody anti-CD25-IgG-IR700 in a mouse model. Four groups were evaluated:
- No treatment
- Anti-CD25-IgG-IR700 i.v. only
- Anti-CD25-F(ab')2-IR700 + NIR irradiation
- Anti-CD25-IgG-IR700 i.v. + NIR irradiation
While both CD25-targeted NIR-PIT approaches significantly suppressed tumor growth, anti-CD25-F(ab')2-IR700 demonstrated superior tumor growth inhibition compared to anti-CD25-IgG NIR-PIT. The absence of the Fc protein in the APC accelerated clearance and promoted more effective activation of T cells within the tumor.
Disclaimer: Medical Supporter translates overseas clinical trial data and pharmaceutical information for informational purposes only. Translation materials are for reference only. Please consult your healthcare provider for medical decisions.
Source: https://bibgraph.hpcr.jp/abst/pubmed/31498995
Animal Study | Photoimmunotherapy | CD25 | Treg
- Discovering the key to aggressive pancreatic cancer!
- New immune enhancers boosting cancer immunotherapy
- Kyoto University launches iPS cell cancer treatment!
Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
هل تفكر في تلقّي العلاج في اليابان؟ هل تحتاج إلى معلومات ومساعدة؟
نساعدك في تنظيم المعلومات اللازمة للسفر الطبي إلى اليابان، والتواصل مع المؤسسات الطبية اليابانية، وترتيب استشارة رأي ثانٍ.الاستشارة الأولى مجانية؛ سيساعدك المستشار على توضيح الخطوات التالية.
Figure 1
Figure 2
Figure 3
Figure 4